Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,995 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
A storied dividend king trades at a discount as Wall Street shifts away. Here’s why patient investors are doubling do...
Beyond Meat's stock has faced a steep slide, but the plant-based meat story isn’t closed. This guide breaks down the ...
London fintech Revolut eyes the U.S. market as it rides a $75 billion valuation and 75 million global customers into ...
A durable, AI-driven demand backdrop is lifting HPE, Jabil, and CrowdStrike, prompting new targets and optimistic ass...
NVIDIA breached a $5.5 trillion market cap, marking a historic leap for a chipmaker tied to AI. The move highlights t...
Cardano faces a pivotal test as founder Charles Hoskinson lays out a four-layer rescue plan blending governance refor...
Economist Peter Schiff argues that current Bitcoin holders could face regrets if they don’t cash out as BTC tests key...
Chevron announces a quarterly dividend of $1.78 per share, marking 39 years of uninterrupted growth. Q4 results show ...
A senior strategist at a massive $1.8 trillion fund warns that long-dated Treasuries are unlikely to shield retiremen...
Bitdeer’s May 2026 update shows a spike in BTC mined alongside a steep drop in BTC held, underscoring the tension bet...